Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial in asthma evaluating the efficacy, safety, and pharmacokinetics of QAV680 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QAV680

Snippet

Sponsor: Novartis | Conditions: Asthma | Phase 2 | Status: COMPLETED